Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Adicet Bio (ACET) has a market cap of $75.644 million USD. According to our data, Adicet Bio is ranked No.7903 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $75.64 M |
-4.57%
|
| Dec 31, 2024 | $79.27 M |
-49.10%
|
| Dec 29, 2023 | $0.16 B |
-78.86%
|
| Dec 30, 2022 | $0.74 B |
-48.89%
|
| Dec 31, 2021 | $1.44 B |
24.48%
|
| Dec 31, 2020 | $1.16 B |
34.71%
|
| Dec 31, 2019 | $0.86 B |
-82.71%
|
| Dec 31, 2018 | $4.97 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
 Atara Biotherapeutics
ATRA
|
$39.68 M |
0.000 M
|
USA
|
 Autolus Therapeutics
AUTL
|
$0.57 B |
0.000 M
|
UK
|
 bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
 Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
 CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
 Editas Medicine
EDIT
|
$0.11 B |
-0.000 M
|
USA
|
 Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 Legend Biotech
LEGN
|
$6.87 B |
0.000 M
|
USA
|
 Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
USA
|
 Sana Biotechnology
SANA
|
$0.78 B |
0.000 M
|
USA
|
| Market Cap | = | ACET Stock Price | * | ACET Shares Outstanding |
| = | $0.92 | * | 82.40 M | |
| = | $75.64 M |